85.38
price down icon1.52%   -1.32
pre-market  Vorhandelsmarkt:  85.69   0.31   +0.36%
loading
Schlusskurs vom Vortag:
$86.70
Offen:
$85.06
24-Stunden-Volumen:
1.82M
Relative Volume:
1.07
Marktkapitalisierung:
$42.23B
Einnahmen:
$9.93B
Nettoeinkommen (Verlust:
$1.12B
KGV:
37.95
EPS:
2.25
Netto-Cashflow:
$1.58B
1W Leistung:
-2.47%
1M Leistung:
-10.43%
6M Leistung:
-3.23%
1J Leistung:
-3.23%
1-Tages-Spanne:
Value
$84.94
$85.72
1-Wochen-Bereich:
Value
$84.94
$87.64
52-Wochen-Spanne:
Value
$80.48
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
Firmenname
Alcon Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
25,599
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
ALC's Discussions on Twitter

Vergleichen Sie ALC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.38 43.30B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
552.41 196.08B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
173.01 49.62B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
RMD
Resmed Inc
244.76 36.04B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
80.12 15.87B 3.93B 415.40M 384.70M 2.06

Alcon Inc Stock (ALC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-20 Herabstufung Deutsche Bank Buy → Hold
2025-05-14 Bestätigt BTIG Research Buy
2025-03-28 Bestätigt Needham Buy
2025-03-25 Hochstufung BofA Securities Neutral → Buy
2025-01-24 Bestätigt Needham Buy
2025-01-10 Hochstufung Redburn Atlantic Neutral → Buy
2024-12-17 Bestätigt Needham Buy
2024-11-12 Bestätigt Needham Buy
2024-10-10 Hochstufung Redburn Atlantic Sell → Neutral
2024-09-10 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-07-15 Hochstufung Morgan Stanley Underweight → Equal-Weight
2024-05-15 Hochstufung Oppenheimer Perform → Outperform
2024-04-10 Eingeleitet Goldman Buy
2024-03-14 Eingeleitet RBC Capital Mkts Sector Perform
2024-02-06 Fortgesetzt KeyBanc Capital Markets Overweight
2024-01-23 Eingeleitet Bernstein Outperform
2023-12-18 Herabstufung Redburn Atlantic Neutral → Sell
2023-12-12 Eingeleitet Stifel Buy
2023-12-04 Herabstufung Morgan Stanley Equal-Weight → Underweight
2023-08-17 Hochstufung JP Morgan Neutral → Overweight
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-05-10 Hochstufung Robert W. Baird Neutral → Outperform
2023-03-01 Hochstufung Societe Generale Sell → Hold
2022-12-22 Eingeleitet Mizuho Buy
2022-11-17 Herabstufung Societe Generale Hold → Sell
2022-08-11 Herabstufung Societe Generale Buy → Hold
2022-05-13 Fortgesetzt Credit Suisse Outperform
2022-05-12 Hochstufung Stephens Equal-Weight → Overweight
2022-04-08 Eingeleitet Needham Buy
2022-03-11 Eingeleitet BofA Securities Buy
2022-01-18 Herabstufung Stephens Overweight → Equal-Weight
2022-01-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-10-01 Eingeleitet Oppenheimer Perform
2021-07-14 Eingeleitet Deutsche Bank Buy
2021-05-06 Hochstufung Citigroup Sell → Neutral
2021-03-22 Hochstufung BTIG Research Neutral → Buy
2020-11-12 Herabstufung Guggenheim Buy → Neutral
2020-07-06 Herabstufung Citigroup Neutral → Sell
2020-07-06 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-06-16 Hochstufung Guggenheim Neutral → Buy
2020-04-08 Herabstufung Robert W. Baird Outperform → Neutral
2020-03-26 Hochstufung Argus Hold → Buy
2020-03-24 Hochstufung Societe Generale Sell → Hold
2020-03-13 Hochstufung UBS Neutral → Buy
2020-03-05 Eingeleitet Citigroup Neutral
2020-02-26 Hochstufung Berenberg Hold → Buy
2020-01-08 Eingeleitet Argus Hold
2019-10-29 Eingeleitet Stephens Equal-Weight
2019-08-21 Bestätigt BofA/Merrill Neutral
2019-06-24 Eingeleitet SVB Leerink Mkt Perform
2019-06-14 Eingeleitet BTIG Research Neutral
2019-05-10 Eingeleitet Robert W. Baird Outperform
2019-05-02 Eingeleitet Credit Suisse Outperform
Alle ansehen

Alcon Inc Aktie (ALC) Neueste Nachrichten

pulisher
05:57 AM

FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment By Investing.com - Investing.com South Africa

05:57 AM
pulisher
05:42 AM

BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch - Investing.com

05:42 AM
pulisher
12:01 PM

Alcon Inc. (ALC)’s TRYPTYR Wins FDA Nod for Dry Eye Disease - Insider Monkey

12:01 PM
pulisher
May 28, 2025

US FDA Approves Alcon's Dry Eye Disease Treatment - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

US FDA approves Alcon’s new dry-eye drug - The Mighty 790 KFGO

May 28, 2025
pulisher
May 28, 2025

Alcon (ALC) Gains FDA Approval for Innovative Dry Eye Treatment - GuruFocus

May 28, 2025
pulisher
May 28, 2025

US FDA approves Alcon's new dry-eye drug - Reuters

May 28, 2025
pulisher
May 28, 2025

Alcon up 4% as FDA approves Tryptyr drops for dry eye - Seeking Alpha

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic s - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Alcon (ALC) Gains FDA Nod for Innovative Dry Eye Treatment | ALC Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment - Investing.com

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Gordon Schanzlin New Vision Institute First in Region to Offer Groundbreaking Alcon Sitemap Technology for Personalized Vision Correction - GlobeNewswire Inc.

May 28, 2025
pulisher
May 28, 2025

BTIG maintains Alcon stock Buy rating, $99 target By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 27, 2025

Trump Says TikTok Agreement Will Not Mirror US Steel Deal - PYMNTS.com

May 27, 2025
pulisher
May 26, 2025

Turkey Contact Lens MarketCompetition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more - Yahoo

May 26, 2025
pulisher
May 26, 2025

U.S. Ophthalmic Photocoagulator Growth Trends and Forecasts 2025-2032 - GlobeNewswire Inc.

May 26, 2025
pulisher
May 25, 2025

FTC Requests More Information on Alcon's $430 Million Acquisition of Lensar - PYMNTS.com

May 25, 2025
pulisher
May 23, 2025

FTC Probing Alcon's $430M Lensar Deal - Law360

May 23, 2025
pulisher
May 22, 2025

Eye care product makers Alcon, LENSAR get second request from US FTC - MLex

May 22, 2025
pulisher
May 22, 2025

Alcon (ALC) Receives Upgrade to Buy from Kepler Cheuvreux | ALC Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Alcon Inc. (NYSE:ALC) Q1 2025 Earnings Call Transcript - MSN

May 22, 2025
pulisher
May 21, 2025

Alcon (ALC): A Key Partner in Lifecore's Revenue Growth Strategy - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Alcon (ALC): A Key Partner in Lifecore's Revenue Growth Strategy | ALC Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Alcon (ALC) - The Globe and Mail

May 21, 2025
pulisher
May 21, 2025

Alcon's (VTX:ALC) Profits May Not Reveal Underlying Issues - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Alcon (VTX:ALC) Strong Profits May Be Masking Some Underlying Issues - simplywall.st

May 21, 2025
pulisher
May 20, 2025

RBC cuts Alcon stock price target to CHF95, keeps Outperform rating - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

RBC Capital Adjusts Price Target for Alcon (ALC) While Maintaining Optimism | ALC Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Stifel maintains Alcon stock Buy rating, $100 target amid new drug launch - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

Deutsche Bank Downgrades Alcon (ALC) Rating, Lowers Price Target | ALC Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Deutsche Bank cuts Alcon stock rating, lowers price target - Investing.com

May 20, 2025
pulisher
May 20, 2025

Deutsche Bank cuts Alcon stock rating, lowers price target By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

RBC cuts Alcon stock price target to CHF95, keeps Outperform rating By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 19, 2025

LENSAR Announces Merger with Alcon Research - TipRanks

May 19, 2025
pulisher
May 18, 2025

Alcon updates 2025 sales growth target to 6%-7% driven by new product launches and tariff mitigation - MSN

May 18, 2025
pulisher
May 16, 2025

Alcon stock target cut to $109 by Bernstein on Q2 outlook - Investing.com Nigeria

May 16, 2025
pulisher
May 15, 2025

Alcon’s Earnings Call: Balancing Growth and Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Alcon (ALC) Sees Notable Increase in Borrow Rate | ALC Stock New - GuruFocus

May 15, 2025
pulisher
May 15, 2025

India Ophthalmic Devices Market Forecast Report 2025-2033, Competitive Analysis of Alcon, Bausch Health, Carl Zeiss, Meditec, Essilor, Hoya, Johnson & Johnson, Nidek, Topcon - Yahoo

May 15, 2025
pulisher
May 15, 2025

Alcon (ALC) Sees Notable Increase in Borrow Rate | ALC Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Alcon Q1 2025 slides: Revenue guidance raised despite margin pressures from tariffs - Investing.com Canada

May 15, 2025
pulisher
May 15, 2025

Alcon Inc (ALC) Q1 2025 Earnings Call Highlights: Resilient Growth Amid Market Challenges - Yahoo

May 15, 2025
pulisher
May 15, 2025

Alcon Revises Outlook As Swiss Market Stays Steady - Finimize

May 15, 2025
pulisher
May 15, 2025

Alcon First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Alcon Inc. Reports Strong Q1 2025 Earnings Growth - TipRanks

May 15, 2025
pulisher
May 14, 2025

Alcon Earnings: Lukewarm Start to Year Raises Stakes for Back Half of 2025; Tariff Impact Mild - Morningstar

May 14, 2025
pulisher
May 14, 2025

Soft First-Quarter Readout Puts Spotlight on Product Launches and Operational Excellence - Morningstar

May 14, 2025

Finanzdaten der Alcon Inc-Aktie (ALC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies RMD
$244.76
price down icon 0.59%
medical_instruments_supplies BDX
$173.01
price down icon 0.86%
medical_instruments_supplies COO
$80.12
price down icon 0.58%
medical_instruments_supplies BAX
$30.58
price down icon 0.94%
medical_instruments_supplies WST
$211.39
price up icon 0.18%
Kapitalisierung:     |  Volumen (24h):